Biotech News & Trading Forum: Community User: Weedmaster

Danke Billi. Aber Guangzhou ist mir zu weit weg, lieber nach Chengdu zu den Pandas.😉 ACST – Acasti Pharma Inc. CaPre (TRILOGY 1 and 2) Hypertriglyceridemia Phase 3 top-*** data due in December 2019 (1) and January 2020 (2). Marketcap: $173 million ALNY – Alnylam Pharmaceuticals Inc. Lumasiran (ALN-GO1) ILLUMINATE-A Primary Hyperoxaluria Type 1 (PH1) Phase 3 data due late-2019. Marketcap: $11.9 billion ARDX – Ardelyx Inc. Tenapanor - PHREEDOM Hyperphosphatemia in end-stage renal disease (ESRD) patients Phase 3 data due 4Q 2019. Marketcap: $403.9 million ATNX – Athenex Inc. Oraxol Metastatic breast cancer Phase 3 top-*** data met primary endpoint (ORR), secondary endpoints (PFS/OS) yet to hit. Presentation due at SABCS December 13, 2019. Marketcap: $1.2 billion AUPH – Aurinia Pharmaceuticals Inc Voclosporin - AURORA Lupus Phase 3 data due 4Q 2019. Marketcap: $577.3 million AXSM – Axsome Therapeutics Inc. AXS-05 -GEMINI Major Depressive Disorder Phase 3 data due 4Q 2019. Marketcap: $1.2 billion BGNE – BeiGene Ltd. Zanubrutinib (BGB-3111) - ASPEN Waldenström’s macroglobulinemia Phase 3 top-*** data due 4Q 2019. Marketcap: $12.5 billion Biogen🤔 War hier auch der Lehrling beteiligt wie bei Inflarx?🤔 BIIB – Biogen Inc. Aducanumab (Aβ mAb) - EMERGE Alzheimer’s disease Phase 3: Noted March 21, 2019 that its Phase 3 trial would be discontinued due to futility - unlikely to meet primary endpoint upon completion. However, noted October 22, 2019 that it intends to submit a BLA filing early 2020 based on data that showed the primary endpoint was met. Detailed data December 5, 2019 at CTAD. Marketcap: $54 billion BMRN – BioMarin Pharmaceutical Inc. Vosoritide Achondroplasia Phase 3 top-*** data due end of 2019. Marketcap: $14 billion CCXI – ChemoCentryx Inc. Avacopan - CCX168 (ADVOCATE) Associated vasculitis (AAV) Phase 3 data due 4Q 2019. Marketcap: $462.7 million OBSV – ObsEva SA OBE2109 - PRIMROSE 2 Uterine fibroids Phase 3 data due 4Q 2019. Marketcap: $132 million SAGE – Sage Therapeutics Inc. SAGE-217 - MOUNTAIN Major Depressive Disorder (MDD) Phase 3 data due 4Q 2019. Marketcap: $7.7 billion SLGL – Sol-Gel Technologies Ltd. TWIN Acne Phase 3 data due 4Q 2019. Marketcap: $161.5 million TGTX – TG Therapeutics Inc. TG-1101 and TGR-1202 - UNITY-CLL study Chronic Lymphocytic Leukemia (CLL) and non-Hodgkin's Lymphoma (NHL) Phase 3 PFS data due late 2019 or early 2020. Marketcap: $724.9 million

Schorsch, ich wünsche dir eine gute Reise, und schaue dir mal tinyi an 😉👋

Kann man mal rein, denke ich

Einen 1 zu 10 RS sogar.

Moin weedi, hat tnxp schon ihren rs vollzogen?

Zeichensprache Weed 😜😂

Erste***=b.ö.s.e.r ,zweite***=K.u.h 🤦

Bei TNXP ist ja gerade richtig Volumen reingekommen. Den Kurs hat es noch nicht großartig bewegt. Sieht interressant aus. Ziemlich *** Abwärtstrend im vorwege. Wenn die Shorter covern müssen,fliegt die ***! 😁

Wünsche Euch viel Glück,das die erhofften News kommen! Ich bin natürlich immer bei Euch,auch wenn es manchmal später wird. 😉

Adxs 💥🤛🏼😁

Tocagen? Gailooooooooooooooooo!! 😀✌️👊

Werde es mir überlegen Schorsch. Tocagen, Advaxis und Proteostasis müssen jetzt liefern! 😁

Genau.... dank RS und anschließender PP reicht das Cash wieder für 6 Monate PREVIOUS CLOSE 1.26$ OPEN 1.22$ PRICE TO BOOK 0.2 MARKET CAP 1,948,800$ SHARES 1,571,740 20 NOVEMBER 2019 Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering 20 NOVEMBER 2019 Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Alcohol Use Disorder 21 NOVEMBER 2019 Tonix Pharmaceuticals Announces Initiation of the Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia

Danke Schorsch, da gab es doch einen 1 zu 10 RS 😅

Moma Tonix Pharmaceuticals wäre doch was für dich: $TNXP $1.2's Bought to support legendary trader & national treasure @professorDman1 & @Ultra_Calls Phase 1 data in Dec, offering closed, & mega low float High short interest so maybe they'll start buying to cover and protect their this month before December. https://t.co/nzL0tm8Qoz

Das wäre doch mal was....💪🏻